Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation

por Friberg, Leif, Oldgren, Jonas
Publicado 2017

Heart failure: a weak link in CHA(2)DS(2)‐VASc

por Friberg, Leif, Lund, Lars H.
Publicado 2018

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation

por Friberg, Leif, Andersson, Tommy, Rosenqvist, Mårten
Publicado 2019

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records

por Friberg, Leif, Gasparini, Alessandro, Carrero, Juan Jesus
Publicado 2018

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks

por Atterman, Adriano, Friberg, Leif, Asplund, Kjell, Engdahl, Johan
Publicado 2021

Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from nati...

por Gurusamy, Venkatesh Kumar, Brobert, Gunnar, Vora, Pareen, Friberg, Leif
Publicado 2019

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

por Friberg, Leif, Benson, Lina, Rosenqvist, Mårten, Lip, Gregory Y H
Publicado 2012

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation

por Tomasdottir, Maria, Friberg, Leif, Hijazi, Ziad, Lindbäck, Johan, Oldgren, Jonas
Publicado 2019

Prognostic implication of premature ventricular contractions in patients without structural heart disease

por Scorza, Raffaele, Jonsson, Martin, Friberg, Leif, Rosenqvist, Mårten, Frykman, Viveka
Publicado 2022

Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure

por Lind, Viktor, Hammar, Niklas, Lundman, Pia, Friberg, Leif, Talbäck, Mats, Walldius, Göran, Norhammar, Anna
Publicado 2021

Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation—Compliance and ease of use in an ambulatory elderly population

por Fredriksson, Tove, Kemp Gudmundsdottir, Katrin, Frykman, Viveka, Friberg, Leif, Al‐Khalili, Faris, Engdahl, Johan, Svennberg, Emma
Publicado 2020

Brief episodes of rapid irregular atrial activity (micro-AF) are a risk marker for atrial fibrillation: a prospective cohort study

por Fredriksson, Tove, Gudmundsdottir, Katrin Kemp, Frykman, Viveka, Friberg, Leif, Al-Khalili, Faris, Engdahl, Johan, Svennberg, Emma
Publicado 2020

New‐Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Outcome: A Population‐Based Nationwide Study From the SWEDEHEART Registry

por Taha, Amar, Nielsen, Susanne J., Bergfeldt, Lennart, Ahlsson, Anders, Friberg, Leif, Björck, Staffan, Franzén, Stefan, Jeppsson, Anders
Publicado 2020

Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels

por Al-Khalili, Faris, Kemp-Gudmundsdottir, Katrin, Svennberg, Emma, Fredriksson, Tove, Frykman, Viveka, Friberg, Leif, Rosenqvist, Mårten, Engdahl, Johan
Publicado 2020

Performance of pulse palpation compared to one‐lead ECG in atrial fibrillation screening

por Gudmundsdottir, Katrin Kemp, Fredriksson, Tove, Svennberg, Emma, Al‐Khalili, Faris, Friberg, Leif, Häbel, Henrike, Frykman, Viveka, Engdahl, Johan
Publicado 2021

Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting

por Taha, Amar, Nielsen, Susanne J., Franzén, Stefan, Rezk, Mary, Ahlsson, Anders, Friberg, Leif, Björck, Staffan, Jeppsson, Anders, Bergfeldt, Lennart
Publicado 2022

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction

por Szummer, Karolina, Gasparini, Alessandro, Eliasson, Staffan, Ärnlöv, Johan, Qureshi, Abdul Rashid, Bárány, Peter, Evans, Marie, Friberg, Leif, Carrero, Juan Jesus
Publicado 2017

Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study

por Kemp Gudmundsdottir, Katrin, Fredriksson, Tove, Svennberg, Emma, Al-Khalili, Faris, Friberg, Leif, Frykman, Viveka, Hijazi, Ziad, Rosenqvist, Mårten, Engdahl, Johan
Publicado 2020

Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study

por Lyth, Johan, Svennberg, Emma, Bernfort, Lars, Aronsson, Mattias, Frykman, Viveka, Al-Khalili, Faris, Friberg, Leif, Rosenqvist, Mårten, Engdahl, Johan, Levin, Lars-Åke
Publicado 2022